Drugs Medical Pharma

Globus Medical buys NuVasive in all-stock for $3.1 billion

Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1.

Read More
X